GENEVA, Oct. 1 -- SHAPE THERAPEUTICS INC. (700 Dexter Ave NSuite 1550Seattle, Washington 98109) filed a patent application (PCT/US2025/020730) for "MECP2-TARGETING ENGINEERED GUIDE RNAS AND POLYNUCLEOTIDES" on Mar 20, 2025. With publication no. WO/2025/199339, the details related to the patent application was published on Sep 25, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAVVA, Yiannis (c/o Shape Therapeutics Inc.700 Dexter Ave NSuite 1550Seattle, Washington 98109), BOOTH, Brian (c/o Shape Therapeutics Inc.700 Dexter Ave NSuite 1550Seattle, Washington 98109), BRIGGS, Adrian Wrangham (c...